Newsroom | 188749 results

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the third quarter ended September 30, 2026. “We delivered higher than expected topline growth in the third quarter, with revenues up 6.3% sequentially, despite continued market softness. This first step in restoring growth reflects sequential improvement across all our businesses. The actions we initiated last quarter to improve commercia...

NEWARK, Calif.--(BUSINESS WIRE)--Corsair Pharma Announces Positive Outcome from FDA Pre-IND Meeting for TRX-248 Transdermal System for Pulmonary Arterial Hypertension (PAH)...

ENGLEWOOD, N.J.--(BUSINESS WIRE)--Phase 2/3: CD206-targeted glucocorticoid 101-PGC-005 beat dexamethasone (HR 2.31), no added steroid; ACR 2026 poster data; partners sought...

SAN DIEGO--(BUSINESS WIRE)--Inocras Inc., a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to deliver curated insights, today announced that it will present the first public results from its multimodal agentic AI framework for automating variant curation and clinical interpretation of cancer whole-genome sequencing (WGS) analysis at the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo, taking place November 10–14 in Seattle...

LOVELAND, Colo.--(BUSINESS WIRE)--Parasites & Vectors study: Antech’s KeyScreen™ GI Parasite PCR found parasites in twice as many samples as antigen testing and flotation combined....

SAN DIEGO--(BUSINESS WIRE)--Qureator, a leading techbio company delivering regulatory-grade translational data through its vTIME 3D human tissue platform, presented preclinical data evaluating the dual pharmacology of a PD-1xVEGF bispecific antibody and the vascular safety profile of a T-cell engager in a poster at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting. “Developing effective cancer therapies requires a deeper understanding of how treatments interact with the complex...

FRISCO, Texas--(BUSINESS WIRE)--Valify, the healthcare industry's leading technology-enabled purchased services platform, hosted its third annual Summit, bringing together healthcare executives, supply chain leaders, strategic sourcing professionals and industry experts from across the country to explore the trends, technologies and strategies shaping the future of healthcare operations. The event featured thought leadership, peer collaboration and practical insights designed to help health sys...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Total revenue of $35.1 million, compared with $20.6 million in the third quarter of 2025 HEPZATO KIT™ revenue of $32.7 million, compared to $19.3 million in the third quarter of 2025...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2026, and provided corporate updates. “We are executing with discipline as we complete the final steps toward our planned BLA submission for TA-ERT in December, which we believ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in fireside chats at the following upcoming investor conferences. Jefferies Global Healthcare Conference in London, UK on Tuesday, November 17; fireside chat at 3:00 pm Greenwich Mean Time 9th Annual Evercore Healt...